The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet
Apr 18
Israeli (TA) Biotech Industry Analysis
UpdatedMay 30, 2023
DataAggregated Company Financials
Companies14
- 7D4.0%
- 3M17.7%
- 1Y-19.6%
- YTD17.9%
The Biotech industry is up 4.0% in the last week, with Kamada up 7.8%. In the past year, the industry is down 20%. Looking forward, earnings are forecast to grow by 39% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 May 2023 | ₪1.9b | ₪550.9m | -₪404,371,812.00 | n/a | -4.6x | 3.4x |
| Thu, 27 Apr 2023 | ₪1.7b | ₪528.8m | -₪366,035,634.00 | n/a | -4.5x | 3.1x |
| Sat, 25 Mar 2023 | ₪1.5b | ₪604.9m | -₪451,670,960.00 | 2.3x | -3.4x | 2.5x |
| Mon, 20 Feb 2023 | ₪1.6b | ₪548.7m | -₪471,922,239.00 | 4.8x | -3.4x | 2.9x |
| Wed, 18 Jan 2023 | ₪1.7b | ₪521.5m | -₪467,065,915.00 | 17x | -3.7x | 3.3x |
| Fri, 16 Dec 2022 | ₪1.5b | ₪523.8m | -₪468,624,868.00 | 17.4x | -3.2x | 2.9x |
| Sun, 13 Nov 2022 | ₪1.8b | ₪481.1m | -₪478,147,988.00 | 18.6x | -3.7x | 3.7x |
| Tue, 11 Oct 2022 | ₪1.8b | ₪493.9m | -₪487,503,618.00 | 18.3x | -3.8x | 3.7x |
| Thu, 08 Sep 2022 | ₪2.0b | ₪463.9m | -₪434,812,348.00 | 9x | -4.7x | 4.4x |
| Sat, 06 Aug 2022 | ₪2.1b | ₪483.3m | -₪394,117,510.00 | 13x | -5.3x | 4.4x |
| Mon, 04 Jul 2022 | ₪2.1b | ₪501.2m | -₪406,180,495.00 | 12.1x | -5.2x | 4.2x |
| Wed, 01 Jun 2022 | ₪2.2b | ₪480.4m | -₪433,654,590.00 | 13.8x | -5.2x | 4.7x |
| Fri, 29 Apr 2022 | ₪2.8b | ₪469.9m | -₪502,126,014.00 | 14.1x | -5.5x | 5.9x |
| Sun, 27 Mar 2022 | ₪2.8b | ₪458.6m | -₪219,714,905.00 | 3.4x | -12.9x | 6.2x |
| Tue, 22 Feb 2022 | ₪2.8b | ₪458.6m | -₪221,532,980.00 | 7.1x | -12.6x | 6.1x |
| Thu, 20 Jan 2022 | ₪3.4b | ₪450.8m | -₪216,099,920.00 | 7x | -15.8x | 7.6x |
| Sat, 18 Dec 2021 | ₪3.5b | ₪432.6m | -₪210,459,450.00 | 9.6x | -16.6x | 8.1x |
| Mon, 15 Nov 2021 | ₪4.0b | ₪461.6m | -₪166,976,021.00 | 10x | -23.8x | 8.6x |
| Wed, 13 Oct 2021 | ₪4.1b | ₪476.1m | -₪174,405,379.00 | 10.3x | -23.3x | 8.5x |
| Fri, 10 Sep 2021 | ₪4.3b | ₪479.4m | -₪177,420,697.10 | 7.2x | -24x | 8.9x |
| Sun, 08 Aug 2021 | ₪4.0b | ₪483.2m | -₪167,305,098.00 | 4.5x | -23.9x | 8.3x |
| Sat, 01 May 2021 | ₪4.2b | ₪528.7m | -₪109,530,611.00 | 3.6x | -38.1x | 7.9x |
| Tue, 02 Feb 2021 | ₪4.3b | ₪520.8m | -₪60,037,930.40 | 2.8x | -71x | 8.2x |
| Fri, 06 Nov 2020 | ₪2.7b | ₪546.7m | -₪199,116,926.70 | 9.9x | -13.3x | 4.9x |
| Mon, 10 Aug 2020 | ₪2.4b | ₪541.9m | -₪227,418,479.00 | 10.9x | -10.5x | 4.4x |
Price to Earnings Ratio
-7.1x
Current Industry PE
- Investors are pessimistic on the Israeli Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 3.7% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | -2.55% | |
| Healthcare | -1.74% | |
| Biotech | 3.95% | |
| Biotech | 3.95% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| KMDA Kamada | ₪19.15 | 7.8% +₪62.4m | 30.4% | PS1.7x | |
| CANF Can-Fite BioPharma | ₪0.031 | 10.7% +₪3.7m | -70.5% | PS12.6x | |
| BLRX BioLineRx | ₪0.36 | 1.1% +₪3.7m | 9.2% | PB2.3x | |
| EVGN Evogene | ₪2.37 | 1.4% +₪1.3m | -20.9% | PS15.9x | |
| GRAC Grace Breeding | ₪7.31 | 5.2% +₪1.3m | -74.5% | PS124x |